Global Closed Drug Transfer Systems Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Closed Drug Transfer Systems Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.

According to our (Global Info Research) latest study, the global Closed Drug Transfer Systems market size was valued at US$ 995 million in 2023 and is forecast to a readjusted size of USD 3346 million by 2030 with a CAGR of 19.1% during review period.

North America is the largest Closed Drug Transfer Systems market with about 73% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are BD Medical, Inc, Equashield, LLC, ICU Medical, Inc, Teva Medical Ltd, Corvida Medical etc. Top 3 companies occupied about 74% market share.

This report is a detailed and comprehensive analysis for global Closed Drug Transfer Systems market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Closed Drug Transfer Systems market size and forecasts, in consumption value ($ Million), 2019-2030

Global Closed Drug Transfer Systems market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Closed Drug Transfer Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Closed Drug Transfer Systems market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Closed Drug Transfer Systems

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Closed Drug Transfer Systems market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD Medical, Inc, Equashield, LLC, ICU Medical, Inc, Teva Medical Ltd, Corvida Medical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Closed Drug Transfer Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Closed Drug Transfer Systems market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Closed Vial Access Devices
Closed Syringe Safety Devices
Closed Bag/Line Access Devices

Market segment by Application
Hospital
Clinic

Market segment by players, this report covers
BD Medical, Inc
Equashield, LLC
ICU Medical, Inc
Teva Medical Ltd
Corvida Medical

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Closed Drug Transfer Systems product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Closed Drug Transfer Systems, with revenue, gross margin, and global market share of Closed Drug Transfer Systems from 2019 to 2024.

Chapter 3, the Closed Drug Transfer Systems competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Closed Drug Transfer Systems market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Closed Drug Transfer Systems.

Chapter 13, to describe Closed Drug Transfer Systems research findings and conclusion.